← Open Payments lookup

LINDSEY MILLER: Open Payments

NPI 1770173114 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,557 in 190 payments from 24 companies in 2025. Trend: 2023 $2,959 · 2024 $3,203 · 2025 $3,557

Food & beverage: $3,557
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP32$754
Viatris Specialty LLC32$454
GlaxoSmithKline, LLC.25$324
Grifols USA, LLC12$284
GENZYME CORPORATION11$278
Regeneron Healthcare Solutions, Inc.9$215
Boehringer Ingelheim Pharmaceuticals, Inc.12$212
JAZZ PHARMACEUTICALS INC.8$173
Verona Pharma, Inc.10$163
United Therapeutics Corporation7$137

Products named: DUPIXENT, YUPELRI, TEZSPIRE, Prolastin-C Liquid, FASENRA, XYWAV, TRELEGY ELLIPTA, Ohtuvayre.

Industry payments across MS — which companies pay providers there.